BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10394886)

  • 1. Comparison of alterations of chromosome 17 in carcinoma of the ovary and of the breast.
    Caduff RF; Svoboda-Newman SM; Ferguson AW; Frank TS
    Virchows Arch; 1999 Jun; 434(6):517-22. PubMed ID: 10394886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors.
    Saito H; Inazawa J; Saito S; Kasumi F; Koi S; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
    Cancer Res; 1993 Jul; 53(14):3382-5. PubMed ID: 8100738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma.
    Quezado MM; Moskaluk CA; Bryant B; Mills SE; Merino MJ
    Hum Pathol; 1999 Feb; 30(2):203-7. PubMed ID: 10029450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of histologic homologues of endometrial and ovarian carcinoma.
    Caduff RF; Svoboda-Newman SM; Bartos RE; Ferguson AW; Frank TS
    Am J Surg Pathol; 1998 Mar; 22(3):319-26. PubMed ID: 9500773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
    Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
    Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1.
    Godwin AK; Vanderveer L; Schultz DC; Lynch HT; Altomare DA; Buetow KH; Daly M; Getts LA; Masny A; Rosenblum N
    Am J Hum Genet; 1994 Oct; 55(4):666-77. PubMed ID: 7942844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors.
    Esteller M; Silva JM; Dominguez G; Bonilla F; Matias-Guiu X; Lerma E; Bussaglia E; Prat J; Harkes IC; Repasky EA; Gabrielson E; Schutte M; Baylin SB; Herman JG
    J Natl Cancer Inst; 2000 Apr; 92(7):564-9. PubMed ID: 10749912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
    Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
    J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of heterozygosity on chromosome 17q in epithelial ovarian tumors: association with carcinomas with serous differentiation.
    Garcia A; Bussaglia E; Machin P; Matias-Guiu X; Prat J
    Int J Gynecol Pathol; 2000 Apr; 19(2):152-7. PubMed ID: 10782412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of loss of heterozygosity of the tumor suppressor genes p53 and BRCA1 in ovarial carcinomas].
    Petrović B; Perović M; Novaković I; Atanacković J; Popović B; Luković L; Petković S
    Vojnosanit Pregl; 2006 Sep; 63(9):813-8. PubMed ID: 17039893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity in P53, BRCA1, and estrogen receptor genes and correlation to expression of p53 protein in ovarian epithelial tumors of different cell types and biological behavior.
    Otis CN; Krebs PA; Quezado MM; Albuquerque A; Bryant B; San Juan X; Kleiner D; Sobel ME; Merino MJ
    Hum Pathol; 2000 Feb; 31(2):233-8. PubMed ID: 10685639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early loss of heterozygosity on 17q in ovarian cancer. The Abe Ovarian Cancer Genetics Group.
    Eccles DM; Russell SE; Haites NE; Atkinson R; Bell DW; Gruber L; Hickey I; Kelly K; Kitchener H; Leonard R
    Oncogene; 1992 Oct; 7(10):2069-72. PubMed ID: 1408149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity on chromosome 13q12-q14, BRCA-2 mutations and lack of BRCA-2 promoter hypermethylation in sporadic epithelial ovarian tumors.
    Gras E; Cortes J; Diez O; Alonso C; Matias-Guiu X; Baiget M; Prat J
    Cancer; 2001 Aug; 92(4):787-95. PubMed ID: 11550149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.
    Andersen TI; Gaustad A; Ottestad L; Farrants GW; Nesland JM; Tveit KM; Børresen AL
    Genes Chromosomes Cancer; 1992 Mar; 4(2):113-21. PubMed ID: 1373310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas.
    Papp J; Csokay B; Bosze P; Zalay Z; Toth J; Ponder B; Olah E
    Br J Cancer; 1996 Nov; 74(10):1592-7. PubMed ID: 8932340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Very frequent loss of heterozygosity throughout chromosome 17 in sporadic ovarian carcinoma.
    Foulkes WD; Black DM; Stamp GW; Solomon E; Trowsdale J
    Int J Cancer; 1993 May; 54(2):220-5. PubMed ID: 8098014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
    Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
    Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity in normal tissue adjacent to breast carcinomas.
    Deng G; Lu Y; Zlotnikov G; Thor AD; Smith HS
    Science; 1996 Dec; 274(5295):2057-9. PubMed ID: 8953032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of three regions on chromosome 17q in primary human breast carcinomas which are frequently deleted.
    Cropp CS; Champeme MH; Lidereau R; Callahan R
    Cancer Res; 1993 Dec; 53(23):5617-9. PubMed ID: 8242614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.